Early-Stage hepatitis b drug trial halted
NCT ID NCT05763576
First seen Jan 27, 2026 · Last updated May 01, 2026 · Updated 12 times
Summary
This early-phase study tested a new medicine called RO7565020 in healthy volunteers and people with chronic hepatitis B. The goal was to check safety, side effects, and how the drug moves through the body. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang Gung Medical Foundation Linkou Branch
Taoyuan, 333, Taiwan
-
Faculty of Medicine Siriraj Hospital
Bangkok, 10700, Thailand
-
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, 24253, South Korea
-
Hospital Alvaro Cunqueiro
Vigo, Pontevedra, 36312, Spain
-
Maharaj Nakorn Chiang Mai Hospital
Chiang Mai, 50200, Thailand
-
New Zealand Clinical Research - Auckland
Auckland, 1010, New Zealand
-
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Quest Clinical Research
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.